Join Nilogen on June 21st from 3:00-6:00pm at the MassBio HUB for an event dedicated to the importance of the tumor microenvironment in translational drug discovery and development. The event will feature a two part plenary session with a presentation session and panel discussion, followed by a networking reception featuring cocktails and hors d’oeuvres.

Agenda:
2:30-3:00pm: Registration & Networking

3:00-3:05pm: Introduction

3:05-3:35pm: Plenary Presentation: “Tumoroids for Translational Drug Discovery & Development”
Presenter: Dr. Soner Altiok, M.D. PhD, Founder & CSO, Nilogen Oncosystems

3:35-4:20pm: Panel Discussion: “Challenges in IO Drug Discovery, Development, and Clinical Translation”
Moderator: Rikhia Chakraborty PhD, VP, R&D & Operations, Nilogen Oncosystems
Panelists:

• Johanna Kaufmann PhD, EVP Oncology, Codagenix
• Shilpa Demes PhD, Director, Translational Science, Astellas Pharma
• Khalid Shah M.S. PhD, Vice Chairman of Research, Neurosurgery, Brigham & Women’s Hospital
• Soner Altiok M.D. PhD, Founder & CSO, Nilogen Oncosystems

4:20-6:00pm: Networking Reception